United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UTHR | ONC | NBIX | ||
| Company | United Therapeutic | Beone Medicines Ltd | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 483.81 | 346.74 | 138.75 | ||
| High | 489.50 | 354.63 | 142.15 | ||
| Low | 481.95 | 340.00 | 138.27 | ||
| Latest | 485.36 | 353.92 | 141.20 | ||
| Change | +6.43 | +6.92 | +3.27 | ||
| % Change | +1.34% | +1.99% | +2.37% | ||
| Volume | 297,100 | 269,600 | 1,154,000 | ||
| 20-Day Average Volume | 341,995 | 296,435 | 1,057,340 | ||
| Previous Close | 478.93 | 347.00 | 137.93 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 474.44 | 342.94 | 135.80 | ||
| 20-Day Raw Stochastic | 78.99% | 95.02% | 92.72% | ||
| 20-Day Relative Strength | 53.60 | 58.52 | 52.79 | ||
| Weighted Alpha | +36.86 | +56.62 | +16.17 | ||
| Today's Opinion | 56% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 56% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 96% Buy | 64% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.38% since 01/30/26 | +3.98% since 01/30/26 | +3.78% since 01/30/26 | ||
| Low | 466.01 on 02/02/26 | 328.91 on 02/02/26 | 135.00 on 02/02/26 | ||
| High | 489.50 on 02/06/26 | 355.43 on 02/04/26 | 142.15 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -3.45% since 01/06/26 | +10.48% since 01/06/26 | +2.80% since 01/06/26 | ||
| Low | 455.63 on 01/20/26 | 317.97 on 01/08/26 | 129.17 on 01/20/26 | ||
| High | 509.40 on 01/07/26 | 355.43 on 02/04/26 | 142.15 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +6.91% since 11/06/25 | +6.49% since 11/06/25 | -8.79% since 11/06/25 | ||
| Low | 444.04 on 11/07/25 | 299.50 on 12/16/25 | 129.17 on 01/20/26 | ||
| High | 519.99 on 12/23/25 | 385.22 on 11/17/25 | 160.18 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +60.50% since 08/06/25 | +18.56% since 08/06/25 | +9.94% since 08/06/25 | ||
| Low | 292.34 on 08/12/25 | 280.11 on 08/08/25 | 123.67 on 08/08/25 | ||
| High | 519.99 on 12/23/25 | 385.22 on 11/17/25 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,621,284 | 38,053,064 | 13,752,448 | ||
| Shares Outstanding, K | 43,057 | 109,663 | 99,706 | ||
| Annual Sales | 2,877,400,000 | 3,810,240,000 | 2,355,300,000 | ||
| Annual Net Income | 1,195,100,000 | -644,790,000 | 341,300,000 | ||
| Last Quarter Sales | 799,500,000 | 1,412,280,000 | 794,900,000 | ||
| Last Quarter Net Income | 338,700,000 | 124,840,000 | 209,500,000 | ||
| 60-Month Beta | 0.85 | 0.52 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 7.16 on 10/29/25 | 1.09 on 11/06/25 | 2.04 on 10/28/25 | ||
| Latest Earnings Date | 02/25/26 | 02/26/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.29 | 204.65 | 32.98 | ||